While treating an HIV-infected patient for lung cancer, a cancer drug caused a “drastic and persistent decrease” in viral reservoirs, raising hopes of a new HIV treatment.

Doctors at the Pitie-Salpetriere Hospital in Paris may have found a cancer therapy that is also a highly effective human immunodeficiency virus (HIV) treatment. In a letter written to Annals of Oncology, the group explained that a cancer drug, nivolumab, a drug sold by Bristol Myers Squibb under the tradename Opdivo, dramatically reduced HIV reservoirs.

Read the full articel at labiotech.eu

Investors newsletter

Examples of our topics:

  • Innovations of healthcare start-ups
  • Chances for healthcare investors
  • Equity crowdfunding strategies